T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
1901
Centerspace
CSR
$939M
| $781K | ﹤0.01% |
15,912
+3,419
| +27% | +$183K |
|
1902
Planet Fitness
PLNT
$3.71B
| $778K | ﹤0.01% |
14,518
+3,987
| +38% | +$204K |
|
1903
United Bankshares
UBSI
$6.68B
| $777K | ﹤0.01% |
24,991
-12,934
| -34% | -$437K |
|
|
CNSL
1904
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $775K | ﹤0.01% |
78,440
+26,729
| +52% | +$329K |
|
|
NVTR
1905
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $775K | ﹤0.01% |
47,431
+5,120
| +12% | +$97.9K |
|
1906
National Beverage
FIZZ
$2.93B
| $774K | ﹤0.01% |
21,564
+380
| +2% | +$17.5K |
|
1907
Kratos Defense & Security Solutions
KTOS
$11.8B
| $768K | ﹤0.01% |
54,490
-19,141
| -26% | -$264K |
|
1908
Medifast
MED
$128M
| $767K | ﹤0.01% |
6,138
+192
| +3% | +$32.8K |
|
|
BRKL
1909
DELISTED
Brookline Bancorp
BRKL
| $764K | ﹤0.01% |
55,266
+12,839
| +30% | +$194K |
|
|
NAVG
1910
DELISTED
Navigators Group Inc
NAVG
| $763K | ﹤0.01% |
10,980
+37
| +0.3% | +$2.56K |
|
1911
Opko Health
OPK
$1.04B
| $762K | ﹤0.01% |
253,046
+141,981
| +128% | +$481K |
|
1912
Coherent
COHR
$64B
| $761K | ﹤0.01% |
23,445
+119
| +0.5% | +$4.44K |
|
1913
NETGEAR
NTGR
$647M
| $761K | ﹤0.01% |
14,632
+2,656
| +22% | +$143K |
|
1914
O-I Glass
OI
$1.05B
| $760K | ﹤0.01% |
44,101
-26,518
| -38% | -$463K |
|
|
AKRX
1915
DELISTED
Akorn Inc
AKRX
| $757K | ﹤0.01% |
223,422
+190,010
| +569% | +$1.13M |
|
1916
H.B. Fuller
FUL
$3.24B
| $749K | ﹤0.01% |
17,549
+120
| +0.7% | +$5.43K |
|
|
EFII
1917
DELISTED
Electronics for Imaging
EFII
| $749K | ﹤0.01% |
30,202
+78
| +0.3% | +$2.25K |
|
|
TSE
1918
DELISTED
Trinseo
TSE
| $743K | ﹤0.01% |
16,238
-2,095
| -11% | -$114K |
|
|
ICPT
1919
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $741K | ﹤0.01% |
7,347
-501
| -6% | -$51.9K |
|
|
MEET
1920
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $741K | ﹤0.01% |
159,941
+55,024
| +52% | +$235K |
|
1921
EXL Service
EXLS
$5.36B
| $739K | ﹤0.01% |
70,255
+25,295
| +56% | +$294K |
|
1922
SPX Corp
SPXC
$10.6B
| $739K | ﹤0.01% |
26,397
+4,984
| +23% | +$146K |
|
|
PEI
1923
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $738K | ﹤0.01% |
8,284
-253
| -3% | -$31.5K |
|
1924
Natural Health Trends
NHTC
$15.4M
| $736K | ﹤0.01% |
39,811
+5,915
| +17% | +$130K |
|
1925
Old National Bancorp
ONB
$10.4B
| $736K | ﹤0.01% |
47,784
+17,467
| +58% | +$312K |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.